Clicky

Daxor Corporation(DXR)

Description: Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.


Keywords: Science Hypertension Disorders Hematology Radiology Heart Failure Anemia Blood Transfusion Medicine Red Blood Cell Kidney Failure Medical Device Manufacturing Hematopathology Blood Transfusion Polycythemia Blood Volume Syncope

Home Page: www.daxor.com

DXR Technical Analysis

109 Meco Lane
Oak Ridge, TN 37830
United States
Phone: 212 330 8500


Officers

Name Title
Mr. Michael Richard Feldschuh Chairman, Pres & CEO
Mr. Jonathan Adam Feldschuh Chief Scientific Officer & Director
Mr. Robert J. Michel CPA, CPA, M.B.A. CFO, Chief Compliance Officer & Corp. Sec.
Ms. Kathryn A. Kornafel VP of Marketing & Commercial Devel.
Mr. Guido Manzo VP of Sales
Ms. Jean Oertel Sr. VP Commercialization & Customer Experience

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 8.9095
Price-to-Book MRQ: 2.0645
Price-to-Sales TTM: 144.6185
IPO Date: 1992-03-17
Fiscal Year End: December
Full Time Employees: 0
Back to stocks